0001576427-23-000083.txt : 20230607 0001576427-23-000083.hdr.sgml : 20230607 20230607160831 ACCESSION NUMBER: 0001576427-23-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230605 FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Balla Nathalie CENTRAL INDEX KEY: 0001711277 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36153 FILM NUMBER: 23999045 MAIL ADDRESS: STREET 1: C/O CRITEO, 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Criteo S.A. CENTRAL INDEX KEY: 0001576427 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 BUSINESS PHONE: 33140402290 MAIL ADDRESS: STREET 1: 32 RUE BLANCHE CITY: PARIS STATE: I0 ZIP: 75009 4 1 wf-form4_168616850077547.xml FORM 4 X0407 4 2023-06-05 0 0001576427 Criteo S.A. CRTO 0001711277 Balla Nathalie C/O CRITEO LEGAL DEPT. 387 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 1 0 0 0 0 Ordinary Shares 2023-06-05 4 M 0 6095 18.71 A 23895 D Ordinary Shares 2023-06-05 4 S 0 6095 33.50 D 17800 D Non-employee Warrant (right to buy) 18.71 2023-06-05 4 M 0 6095 0 D 2029-10-24 Ordinary Shares 6095.0 3302 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.71 using the exchange rate as of June 5, 2023 (1.00 = $ 1.073). For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.44 to $33.685 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029. /s/ Ryan Damon, as attorney-in-fact for Nathalie Balla 2023-06-07